1. From the Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom (G.Y.H.L.)
2. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, United Kingdom (G.Y.H.L.)
3. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.)
4. Health Economics and Outcomes Research, STATinMED Research, Ann Arbor, MI (A.K.)
5. Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb Company, Lawrenceville, NJ (X. Li, M.H.)
6. Patient Health & Impact, Outcomes & Evidence, Pfizer, Inc, New York, NY (C.M., J.M.)
7. US Health Economics and Outcomes Research, Bristol-Myers Squibb Company, Lawrenceville, NJ (K.G., A.N.)
8. Patient Health & Impact, Outcomes & Evidence, Pfizer, Inc, Groton, CT (X. Luo)
9. Worldwide Medical, Bristol-Myers Squibb Company, Lawrenceville, NJ (K.F.)
10. Center for Observational Research and Data Sciences, Bristol-Myers Squibb Company, Lawrenceville, NJ (X.P.)
11. Deparment of Internal Medicine, University of Michigan, Ann Arbor (O.B.)
12. Department of Hospital Medicine, Ochsner Clinic Foundation, New Orleans, LA; and Ochsner Clinical School, University of Queensland School of Medicine, New Orleans, LA (S.D.).